TODAYS DATE: Saturday Feb 04, 2012 YOUR ONLINE RESOURCE FOR NEWS ABOUT MESOTHELIOMA

New Clinical Trial for Treatment of Mesothelioma

Friday, March 6th, 2009

Morphotek has announced the beginning of a phase II clinical trial investigating the efficacy of the monoclonal antibody MORAb-009 for the treatment of mesothelioma. The study will evaluate progression-free survival in patients with advanced pleural mesothelioma who are being receiving MORAb-009 in combination with the standard mesothelioma treatment regimen, pemetrexed + cisplatin.
Continue Reading >

image

Contributing Author

Wade Rawlins is a former environmental reporter with the Raleigh News & Observer.

Editorial Board

  • Mike Dayton, Editor
  • Nancy Meredith, Writer
  • Aaron Phelps, Writer
  • Lisa Vaughn, Contributor
Belluck & Fox

We Have Won Our Clients More Than $500 million.

Copyright About Mesothelioma.net
Website by Consultwebs.com